原发性高血压患者不同中医体质间早期肾损害指标比较及相关性分析
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:分析原发性高血压患者不同中医体质类型间早期肾损害指标的差异性及相关性,探讨影响高血压早期肾损害的因素,为早期预防、诊断高血压肾损害提供依据,同时为中医药个体化治疗原发性高血压早期肾损害寻求客观依据和探索新的思路。
     方法:在东直门医院病房及门诊筛选原发性高血压患者,根据相应的纳入、排除标准进行病例收集,签署知情同意书,采集患者的一般资料及高血压相关情况,测量血压,填写中医体质量表并根据《中医体质分类判定标准》对其进行中医体质分类,留取患者晨起尿液标本送至东直门医院检验科检测早期肾病尿液蛋白检查四项(MALB、TRF、β2-MG、 α1-MG),晨起空腹抽取静脉血送至东直门医院检验科生化室检测血糖、胰岛素、肌酐、尿素氮、甘油三酯、胆固醇。最后对采集的数据资料进行统计分析。
     结果:
     1基本资料:本研究有450例原发性高血压患者入组,年龄18~80岁,平均年龄68.42±14.78岁。其中男性240例(53.3%),平均年龄66.86±16.39岁;女性210例(46.7%),平均年龄70.20±12.48岁。高血压病程0.1~60年,平均病程16.60±14.22年。文化程度以小学居多,初中、高中次之。女性平均年龄要高于男性;女性平均身高比男性低11.73cm;男性BMI略高于女性,但差异无统计学意义。男性吸烟、饮酒率均明显高于女性。
     2BMI与空腹血糖(FBG)、空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)之间的相关性。BMI≥26组的FINS、HOMA-IR要高于BMI<24组和24≤BMI<26组的。BMI<24组与24≤BMI<26组之间FINS、HOMA-IR差异无统计学意义。三组间总体FBG差异无统计学意义。
     3降压药服用及血压控制情况。服用降压药者354例(78.7%),未服用降压药者96例(21.3%);服药患者中规律服药者321例,占90.68%,未规律服药者33例,占9.32%。服用降压药患者的血压达标率明显高于未服用降压药患者的血压达标率。规律服用降压药患者的血压达标率明显高于不规律服用降压药患者的血压达标率。所有服用降压药中,ARB类120次,ACEI类27次,CCB类252次,β受体阻滞剂78次,利尿剂69次。CCB类降压药服用频次最高,ARB类次之。CCB类降压药使用率明显高于其他类。CCB类降压药与血压达标率呈显著正相关,即:CCB类降压药仍是控制血压达标的第一选择。
     4高血压中医体质情况。450例原发性高血压患者中,平和质有48例(10.7%),单一偏颇体质中以阴虚质55例最多(12.2%),瘀血质及湿热质次之,各有40例(8.9%),特禀质仅有3例(0.7%)。兼夹体质以两种兼夹体质最多,达76例(16.9%),是分类体质中最多的类型。三种兼夹体质达到43例(9.6%),六种兼夹体质仅有2例(0.4%)。各偏颇体质出现频次,由多到少依次为气虚质,瘀血质,阴虚质,痰湿质,湿热质,气郁质,阳虚质,特禀质。而男女体质构成比有差别。
     5各种中医体质与各因素之间的相关性。平和质与冠心病呈负相关,与血压控制情况呈正相关。气虚质与冠心病呈正相关。阳虚质与年龄、吸烟、高血压家族史呈正相关。阴虚质与脑血管呈正相关。瘀血质与体重指数(BMI)、吸烟呈负相关;与饮酒、冠心病、脑血管病呈正相关。痰湿质与吸烟、冠心病、脑血管病呈正相关;与血压控制情况呈负相关。湿热质与教育程度、BMI、吸烟呈正相关。气郁质与脂代谢异常、血压控制情况呈负相关、与服用降压药呈正相关。
     6不同中医体质间胰岛素抵抗指数(HOMA-IR)差异性比较。159例患者测FBG、FINS,经公式算出HOMA-IR。不同体质间HOMA-IR总体差异具有统计学意义。其中单纯阳虚质HOMA-IR显著高于单纯痰湿质及单纯湿热质者。
     7各偏颇体质(特禀质除外)与平和质之间早期肾损害指标差异性比较。早期肾损害四项指标与性别无关。四项指标在不同中医体质类型组间总体差异均有统计学意义。对四项指标进行各偏颇体质(特禀质除外)与平和质的比较。各偏颇体质的MALB均高于平和质,差异均具有统计学意义,尤以气虚质最高。各偏颇体质的β2-MG均高于平和质,但只有湿热质与平和质比较差异具有统计学意义,余无统计学意义。各偏颇体质的TRF均高于平和质,只有瘀血质与平和质差异无统计学意义,余差异均具有统计学意义,尤以痰湿质最高。各偏颇体质的α1,-MG均高于平和质,只有阳虚质、阴虚质与平和质差异无统计学意义,余差异均具有统计学意义,尤以气郁质最高。
     8早期肾损害指标与各因素回归分析。MALB与文化程度呈正相关,与脂代谢异常、血压控制情况呈负相关。β2-MG与BMI呈正相关。TRF与文化程度、服用降压药呈正相关,与脂代谢异常、血压控制情况呈负相关。α1-MG与吸烟、夜尿次数呈正相关,与服用降压药、血压控制情况呈负相关。
     9早期肾损害指标与服用降压药类别之间的相关性。MALB与是否服用五类降压药均无相关性。β2-MG升高与服用ACEI类降压药呈负相关,即ACEI类降压药可以降低β2-MG。TRF升高与ARB类呈负相关,即ARB类降压药可以降低TRF;TRF升高与CCB类呈正相关,即CCB类降压药使TRF升高。α1-MG升高与ARB类、CCB类呈负相关,即ARB类、CCB类降压药可以降低α1-MG。
     10早期肾损害指标与HOMA-IR回归分析,结果四项指标与HOMA-IR之间均未见其相关性。
     结论:
     1原发性高血压患者中医体质以阴虚质最多,偏颇体质频次以气虚质最为广泛。男女体质构成比不一致。
     2各偏颇体质(特禀质除外)与平和质早期肾损害指标相比,各偏颇体质的高血压早期肾损害程度要比平和质的严重,痰湿质、湿热质、气虚质尤其明显。其中气虚质、痰湿质高血压患者肾小球早期损害最为突出,而湿热质高血压患者最易损伤肾小管。
     3ACEI类降压药可以降低β2-MG;ARB类降压药可以降低TRF;ARB类、CCB类降压药可以降低α1-MG;CCB类降压药可使TRF升高。
     4单纯阳虚质HOMA-IR要高于单纯痰湿质及单纯湿热质者。早期肾损害四项指标与HOMA-IR之间未见其相关性。
Purposes:We was to analyze the difference and correlation about the indexes of early renal damage between the patients with essential hypertension (EH) in different TCM constitutional types, explore the influencing factors of early renal damage caused by EH, provide the basis for prevention and diagnosis of early renal damage caused by EH, seek objective basis and explore new thoughts for the treatment of it by individualization of TCM at the same time.
     Methods:We screened patients with EH according to the relevant inclusion and exclusion criteria in the ward and outpatient of Dongzhimen Hospital, signed informed consent form, gathered the general information and condition relevant to hypertension, measured blood pressure (BP), filled the form of TCM constitution and then classified the type of him according to 《The classified standard of TCM constitution》.His morning urine specimens was sent to the clinical laboratory of Dongzhimen Hospi tal where the four urinary protein indexes (MALB、 TRF、β2-MG、α1-MG)with early nephropathy were tested, at the same time the morning fasting venous blood was tested of blood glucose, insulin, creatinine,urea nitrogen, triglyceride,cholesterol at the clinical biochemical laboratory. Finally,we analyzed the statistics about all the collected data.
     Results:
     1Basic Information:450cases with EH were collected into the study, ages18to80years, mean age68.42±14.78years. There were240cases (53.3%) of men whose mean age was66.86±16.39years old and210cases (46.7%) of women whose mean age was70.20±12.48years old. The course of hypertension was from0.1to60years averaged16.60±14.22years. The case from primary school was the most, junior and senior high school in turn. Women were older than men on average age. Women were lower11.73cm than men on average height. The BMI of men was slightly bigger than women, but there was no statistically significant dif-ference. Smoking and drinking rates of men were significantly higher than women.
     2The correlation between BMI and fasting blood glucose (FBG), fasting insulin (FINS), insulin resistance index (HOMA-IR). FINS and HOMA-IR of group BMI>26were all higher than the groups of BMI<24and24≤BMI<26. There were no statistically significant differences in FINS and HOMA-IR between the groups of BMI<24and24≤BMI<26. There was no statistically significant overall difference between the three groups in FBG.
     3Condition about antihypertensive drugs took and BP.354cases (78.7%) were taking antihypertensive drugs and96cases (21.3%) were not. There were321cases (90.68%) taking antihypertensive drugs regularly, but33cases (9.32%) er-ratically. The rate of reaching the standard in the patients of taking an- tihypertensive drugs was significantly higher than the patients who were not taking antihypertensive drugs. The rate of BP reaching the standard in the patients of taking antihypertensive drugs regularly was significantly higher than the patients who were taking ant ihypertens ive drugs erratically. There were120times of ARB classes,27times of ACE I classes,252times of CCB classes,78times of β-blockers,69t imes of diuretics in all ant ihypertens ive drugs took. The taking frequency of CCB classes was highest and ARB classes secondly. The taking rate of CCB classes was significantly higher than other four classes. There was significantly positively correlation in taking antihypertensive drugs of CCB classes and BP reaching the standard, so they were still the first choices to control BP.
     4Condition of TCM constitution in hypertension. There were48cases of Normal-constitution in450patients with EH, Yin-deficiency constitution which had55cases(12.2%) was the most in the single lopsided constitutions, Blood stasis and Damp-heat constitutions were the second both40cases (8.9%) Special-constitution had only3cases (0.7%).2types combined constitutions which had76cases (16.9%) was the most type in combined constitutions.3types combined constitutions had43cases (9.6%) and6types combined constitutions had only2(0.4%).The turn of appearing frequency from more to less in lopsided constitutions was:Qi-deficiency constitution, Blood stasis constitution, Yin-deficiency constitution, Phlegm-dampness constitution, Damp-heat con-stitution, Qi-stagnation constitution, Yang-deficiency constitution and Special-constitution. There was difference between men and women in the composing of TCM constitution.
     5The correlations between all kinds of TCM constitutions and various factors. Normal-constitution had a negative correlation wi th coronary heart disease (CHD), positive correlation with the condition of BP control. Qi-deficiency con-stitution had a positive correlation with CHD. Yang-deficiency constitution had negative correlations with age, smoking and family history of hypertension. Yin-deficiency constitution had a positive correlation with cerebrovascular disease. Blood stasis constitution had negative correlations with body mass index (BMI) and smoking; positive correlations with drinking, CHD and cere-brovascular disease. Phlegm-dampness constitution had positive correlations with smoking, CHD and cerebrovascular disease; negative correlation with condition of BP control. Damp-heat constitution had positive correlations with education level, BMI, smoking. Qi-stagnation constitution had negative cor-relations with abnormal lipid metabolism and condition of BP control, positive correlation with taking antihypertensive drugs.
     6The difference comparisons between different TCM const i tut ions in HOMA-IR.159patients' FBG, FINS were tested and then HOMA-IR were calculated by formula. There was statistically significant overall difference between different TCM con-stitutions in HOMA-IR. The HOMA-IR of pure Yang-deficiency constitution was significantly higher than pure Phlegm-dampness constitution and pure Damp-heat constitution hot.
     7The difference comparisons between each lopsided constitutions (Spe-cial-constitution excepted) and Normal-constitution in the four indexes of early renal damage. The all four indexes of early renal damage had no correlation with gender, but had significant overall differences between different types of TCM constitutions. Each lopsided constitutions (Special-constitution ex-cepted) compared with Normal-constitution in the four indexes. The MALB of all lopsided constitutions were higher than Normal-constitution and had statistical differences, especially Qi-deficiency constitution's was the highest. The β2-MG of all lops ided constitutions were higher than Normal-constitution, but only the Damp-heat constitution had a statistical difference compared with Nor-mal-constitution, and the other lopsided constitutions had no statistical difference with Normal-constitution. The TRF of all lopsided constitutions were higher than Normal-constitution and had statistical differences except Blood stasis constitution, especially Phlegm-dampness constitution's was the highest. The α1-MG of all lopsided constitutions were higher than Normal-constitution and had statistical differences except Yang-deficiency constitution and Yin-deficiency constitution, especially Qi-stagnation constitution's was the highest.
     8Logistic regression between the four indexes of early renal damage and various factors. MALB had a positive correlation with education level; negative correlations with abnormal lipid metabolism and condition of BP control. β2-MG had a positive correlation with BMI. TRF had posi tive correlations with education level and taking antihypertensive drugs, negative correlations with abnormal lipid metabolism and condition of BP control. α1-MG had positive correlations with smoking and the times of night urination, negative correlations with taking antihypertensive drugs and condition of BP control.
     9The correlations between four indexes of early renal damage and the five types of taking antihypertensive drugs. MALB had no correlation with taking any five antihypertensive drugs. The rise of β2-MG had a negative correlation with taking ACEI drugs, that was to say ACEI drugs can reduce β2-MG. The rise of TRF had a negative correlation with taking ARB drugs, that was to say ARB drugs can reduce TRF. The rise of TRF had a positive taking CCB drugs,that was to say CCB drugs can increase TRF. The rise of α1-MG had negative correlations with taking ARB and CCB drugs, that were to say ARB and CCB drugs can reduce α1-MG.10Regression analyses between the four indexes of early renal damage and HOMA-IR. There was no correlation between the four indexes of early renal damage and HOMA-IR.
     Conclusions:
     1Yin-deficiency constitution is the most in the types of TCM constitutions in the patients with EH, but the frequency of Qi-deficiency constitution is the most in the8lopsided constitutions. There is difference between men and women in the composing of TCM constitution.
     2The difference comparisons between each lopsided constitutions (Spe-cial-constitution excepted) and Normal-constitution in the four indexes of early renal damage. The degree of early renal damage caused by hypertension in8lopsided constitut ions are more serious than Normal-constitution, especially in Phlegm-dampness constitution. Damp-heat constitution and Qi-deficiency constitution. The damage of glomerulus is most special in Qi-deficiency constitution and Phlegm-dampness constitution, however the kidney tubules are more easily damaged by hypertension in Damp-heat constitution.
     3ACE I drugs can reduce (β2-MG; ARB drugs can reduce TRF; ARB and CCB drugs can reduce α1-MG. CCB drugs can increase TRF.
     4The HOMA-IR of pure Yang-deficiency constitution is higher than pure Phlegm-dampness constitution and pure Damp-heat constitution hot. There is no correlation between the four indexes of early renal damage and HOMA-IR.
引文
[1]刘力生,王文,姚崇华.中国高血压防治指南(2009年基本版)(一)[J].中国社区医师,2010,25:8.
    [2]陈香美.高血压引起的肾脏损害[J].中华肾内科杂志,2005,21(10):563-565.
    [3]BidaniAK, Griff in KA.Pathophysiology of hypertensive renal damage:implicat ions for therapy.Hypertension.2004,44:595-601.
    [4]COOPER M E. Pathogenesis,prevention, and treatment of diabetic nephropathy [J]. Lancet,1998,352 (6):213-219.
    [5]Anderson WP, Kett MM,Stevenson KM, et al. Renovascular hypertension:structu ral changes in the renal vasculature. Hypertension,2000,36:648-652.
    [6]RADERMACHER J, FORSTERMANN U,FROLICH J. Endotheliunrderived relaxing facto r influences renal vascular resistance[J]. Am J Physiol,1990,259(1):F9-F17.
    [7]PANZA J A, et al. Abnormal endotheliunr-dependent vascular relaxation in pa tients with essential hypertension[J]. N Eng J Med,1990,323 (1):22-27.
    [8]Garcia-Estan J,Ortiz MC,O'Valle F,et al.Effects of angiotensin-convertin g-enzyme inhibitors in combination with diuretics on blood pressure and rena 1 injury in nitric oxide-deficiency-induced hypertension in rats. Clin Sci,20 06,110:227-233.
    [9]Lavoie P, Robitaille G, Agaharazii M,et al. Involveme Involvement of tra nsforming growth factor-beta in the pathogenesis of hypertension inrats with chronic renal failure. J Hypertens,2004,22(Suppl):80.
    [10]Johnson RJ, Segal MA, Srinivas T, et al. Essential Hypertension, Progressiv e Renal Disease,and Uric Acid:A Pathogenetic Link. J Am Soc Nephrol,2005,16: 1909-1919.
    [11]Tian N, Trasher KD,Gundy PD, et al. Antioxidant treatment prevent renal dam age and dysfunction and reduces arterial pressure in salt-sensitive hyperten sion. Hypertension,2005,94 (suppl):7-15.
    [12]Bidani AK, Griffin KA. Long-term renal consequences of hypertension for no rmal and diseased kidneys. Curr Opin Nephrol Hypertens,2002,11:73-80.
    [13]Palmer BE. Impaired renal autoregulation:implication for the genesis of hypertension and hypertension-induced renal injury. Am J Med Sci,2001,321:38 8-400.
    [14]Hill GS,Heudes D,Jacquot C, et al. Morphometric evidence for impairment o f renal autoregulation in advanced essential hypertension. Kidney Int,2006,69: 823-831.
    [15]吴旭斌,杨成悌,余静,等.炎症在高血压病患者肾功能损害中的作用[J].高血压杂志,2003,11:16-18.
    [16]PATRICIA F P,ESTEBAN D, JOSEB O, et al. Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis[J]. Kid ney Int,1998,53(6):1743-1747.
    [17]付剑云,苏又苏,吴京兰,等.尿微量白蛋白在高血压病早期肾损伤的意义及其与低级别炎症的关系[J].南方医科大学学报,2007,27(5):699-701.
    [18]成威,周胜华,张铭,等.阿托伐他汀对高血压肾病蛋白尿及C-反应蛋白和白介素-6的影响[J].高血压杂志,2005,13:767-770.
    [19]邹斌,吴延庆.活性氧与高血压肾损害关系研究进展[J].中国中西医结合肾病杂志,2004,5:60-62.
    [20]魏永吾,王红.天麻钩藤汤加减配合西药治疗早期高血压肾损伤疗效观察[J].陕西中医,2009,30(8):968-970.
    [21]董光富,叶任高,等.纤溶活性及D-二聚体变化与老年高血压肾损害关系的研究[J].中华老年医学杂志,2000,19(2):112-114.
    [22]Liao YH,Wei YM,Wang M,et al. Auto-antibodies against AT,-Receptor and α1-A drenergic receptor in patients with hypertension [J]. Hypertens Res,2002,25:64 1-646.
    [23]赵林双,廖玉华,王敏,等.血清抗AT1、α1、β1受体自身抗体在高血压合并肾损害患者的初步研究[J].高血压杂志,2006,14:181-184.
    [24]陈义汉,徐文渊,等.遗传和环境因素对高血压患者肾脏损害的影响[J].上海第二医科大学学报,2000,20(6):521-523.
    [25]PATRICIA F P,ESTEBAN D, J OSEB O,et al. Angiotensin converting enzyme gen e I/D polymorphism in essential hypertension and nephroangiosclerosis[J]. K idney Int,1998,53(6):1743-1747.
    [26]徐岩,赵秀珍,赵振霄.高血压肾损害及肾实质性高血压胰岛素受体基因第8外显子多态性分析[J].中华肾脏病杂志,2003,19:123-124.
    [27]Kincaid-Smith P. Hypothesis:obesity and the insulin resistance syndrome p lay a major role in end-stage renal failure attributed to hypertension and 1 abelled hypertensive nephrosclerosis'.J Hypertens,2004,22:1051-1055.
    [28]Weir MR. The role of combination antihypertensive therapy in the preventi on and treatment of chronic kidney disease. Am J Hypertens,2005,18:s100-105.
    [29]王鸿利,仲人前.实验诊断学[M].北京:人民卫生出版社,2004:118.
    [30]Bohm M, Thoenes M,Danchin N, et al.Association of cardiovascular risk fac tors with microalbuminuria in hypertensive individuals:the-SEARCH Global Stu dy[J].J Hypertens,2007,25(11):2317-2324.
    [31]Redon J, Pa scual JM. Development of microalbum inuria in essential hyp ertension[J].CurrHypertens Rep,2006,8 (2):171-177.
    [32]池晓霞,陈剑雄,屠洪.高血压病患者尿蛋白早期肾损害指标联合检测结果分析[J].热带医学杂志,2009,9(3):303-306.
    [33]张德太,宋斌,张科,等.长病程高血压患者早期肾损害多指标检测的意义[J].中国老年学杂志,2008,28(19):1934-1935.
    [34]Viberti GL. Microalbuminuria as predictor of clinical nephropathy in in sulin-depended diabetes Mellitus[J]. Lancet,1982,104:1430-1432.
    [35]余振球.高血压与肾损害[M].北京:北京科学出版社,1993:878-895.
    [36]Leoncini C,Sacchi G,Ravera M, et al. Microalbuminuria is an integrated m arker of subclinical organ damage in primary hypertension[J].J Hum Hypertens, 2002,16(6):3992404.
    [37]Pontremoli R, Leoncini G,RaveraM,et al. Microalbuminuria,cardiovascular,a nd renal risk in p rimary hypertension[[J]. J Am Soc Nephrol,2002,13(3):169-17 2.
    [38]Heim A,Pasche A, Feihl F,et al.Hypertension:ear ly detection of target org an damage[J].RevMed Suisse,2007,3(124):199.
    [39]Bohm M,Reil JC,D anchin N, et al. Association of heart rate with microalb uminuria in cardiovascular risk patients:data from I-SEARCH[J]. Hypertension, 2008,26(1):18-25.
    [40]刘力生,等.中国高血压防治指南2010[J].中华高血压杂志,2011,8(19):701-742.
    [41]张秀明,等.现代临床生化检验学[M].北京:人民军医出版社,2001:29.
    [42]张关亭,等.血清肤抑素、视黄醇结合蛋自、尿微量自蛋自检测对原发性高血压肾病的早期诊断价值[J].慢性病学杂志,2011,12(12):1656.
    [43]严蜀华,等.肾功能指标联合检测对高血压肾损伤早期诊断的价值[J].微循环学杂志,2011,21(3):66.
    [44]Schaub S, Wilkins JA, Antonovici M, et al. Proteomicbased identification o f cleaved urinary β2-microglobulin as a potential marker for acute tubularin jury in renal allografts[J]. Am J Transplant,2005,5:729.
    [45]沈丹,哈黛文.血与尿β2-微球蛋白、免疫球蛋白G及尿白蛋白在老年高血压病患者中的应用[J].中国综合临床,2003,19(1):33-34.
    [46]刘红,等.尿mALB和β2-MG检测对原发性高血压早期肾损害诊断的临床意义[J].西部医学,2011,8(23):1526-1527.
    [47]田卫东,杨志娜,崔征,等.监测血清肤抑素C和尿β2微球蛋白在高血压病诊治中的意义[J].现代中西医结合杂志,2010,19(22):2825.
    [48]马军,蒋金法.高血压合并冠心病患者血、尿β2微球蛋白测定的临床意义[J].同济医科大学学报,2009,30(6):50.
    [49]沈道江,蒋群,叶芳,等.尿视黄醇结合蛋自与尿转铁蛋白诊断传染性单核细胞增多症早期肾损害的价值[J].浙江医学,2007,29(4):309-310.
    [50]魏有仁,朱立华.尿中微量白蛋白的测定及应用[J].生物化学与生物物理进展,1995(2):169-173.
    [51]万军,傅泳航,郑凤娇.尿液微量蛋白联合测定筛查早期肾损害的研究[J].现代中西医结合杂志,2012,21(19):2145-2146.
    [52]梁静,李箐,尹宁,等.高血压病患者转铁蛋白与β2-微球蛋白和微量白蛋白的关系[J].现代生物医学进展,2008,8(7):1299-1301.
    [5f3]万莉莉,孙洞箫.尿蛋白及尿酶测定在高血压肾损害早期诊断的价值[J].中国保健(医学研究版),2007,15(4):76-77.
    [54]严蜀华,等.肾功能指标联合检测对高血压肾损伤早期诊断的价值[J].微循环学杂志,2011,21(3):66-67.
    [55]徐志伟,等.原发性高血压早期肾损害检测血清Y-痕迹蛋白、尿NAG与尿微量白蛋白的临床意义[J].河北北方学院学报(医学版),2010,27(4):6-7.
    [56]原守平.尿ALB、NAG、THP、α1-MG、TRF对早期诊断高血压肾损害的意义探讨[J].福律医药杂志,2010,32(6):103-104.
    [57]Rask L.The retinol-binding protein[J]. Scan J Clin Lab Invest Suppl,1980. 154:45.
    [58]Bernard AM. Assessment of urinary retinol -binding protein as an index of proximal tubular injury[J]. Clin Chom,1987,33:775.
    [59]Blumsohn A. Stablity of β2-microglobulin and retinol -binding protci n at different values of PH and temperation in normal and pathological urine [J]. Clini Chimi Acta,1990,195:133.
    [60]廖忠,等.五项肾功能指标对高血压早期肾损害的诊断价值评价[M].中国医药指南,2012,10(31):21-23.
    [61]邓荣春,施桥发.视黄醇结合蛋白的临床应用进展[J].实验与检验医学,2012,30(1):40-43.
    [62]刘连红,马艳华,罗建祥.高血压病早期肾损害患者尿视黄醇结合蛋白检测的临床意义[J].实用医学杂志,2010,26(7):1177-1178.
    [63]候巍,杨述红,宣萍.视黄醇结合蛋白测定的临床意义[J].中国实验诊断,2002,6(5):348-349.
    [64]章登珊,等.RBP检测在高血压及糖尿病早期肾损害中的临床应用研究[J].实验与检验医学,2012,30(3):233-238.
    [65]王海英.血清视黄醇结合蛋白在肾病早期诊断价值[J]. Chinese Journal Medicinal Guide,2012,14(10):1816-1818.
    [66]戴翔,于波,蔡伦.视黄醇结合蛋白检测在观察高血压及糖尿病早期肾脏改变中的应用[J].检验医学,2006,21(3):304-305.
    [67]Randers E, Erlandsen EJ.Serum CystatinC as an endogerous marker of t he renal function-a review[J]. Clin Chem Lab Med,1999,37(4):389-395.
    [68]Aksun SA,Ozmen D,Ozmen B,et al. Beta2-microglobulin and CystatinC in typ e2 diabetes:assessment of aiabetic nephropathy[J]. Expelin Endocrinol Diabete s,2004,112(4):195-200.
    [69]Mojiminiyi OA, Abdella N. Evaluation of CystatinC and beta-2 microglobu lin as markers of renal function in patients wit h type2 diabets mellitus[J]. J Diabets Complication,2003,17(3):160-168.
    [70]Jovanovic D, Krstivojevic P,Obradovoc I,et al. Serum CystatinC and beta2-microglobulin as markers of glomerular filtration rate[J].Ren Fail,2003,25 (1):123-133.
    [71]谢华,林洪丽.血清Cystatin C评价慢性肾脏病患者肾小球滤过功能的对照研究[J].中国中西医结合肾病杂志,2006,7(9):514-516.
    [72]李海霞,张春丽,徐国宾,等.健康人群血清半脱产氨酸蛋白抑制剂C与肌酐分布及其评价慢性肾脏病患者肾小球滤过功能的比较研究[J].中华检验医学杂志,2006,29(11):970-974.
    [73]曹国强,宋明辉,陈青松,等.高血压肾损伤早期诊断的多指标检测分析[J].西南军医,2010,12(3):462-463.
    [74]刘红,姜鸿,岳华,等.高血压早期肾损害不同诊断指标临床意义[J].中华实用诊断与治疗杂志,2012,26(5):470-471.
    [75]江福民.尿微量白蛋白和血清胱抑素C联合检测在高血压早期肾损伤中的诊断价值[J].检验与临床,2012,50(14):79-80.
    [76]胥华猛,刘梅华.血清胱抑素C在高血压早期肾损害诊断中的价值[J].国际检验医学杂志,2012,33(9):1126-1127.
    [77]吕春艳,齐铮琴,韩俊岭,等NAG、α1-MG、β2-VMG测定对亚临床肝肾综合征的诊断意义[J].南京医科大学学报(自然科学版),2011,31(2):238-240.
    [78]张燕,山洁,蒋玉红.尿微量白蛋白联合尿酶诊断妊娠期高血压疾病早期肾损害的研究进展[J].中国优生与遗传杂志,2011,19(8):126-127.
    [79]张艳莉,马灵筠,康健.血液微量蛋白在高血压肾病早期诊断中的意义[J].医药论坛杂志,2003,24(20):13-14.
    [80]范丽梅,邵光,徐力堃,等.尿β2-MG及微量白蛋白检测在妊娠糖尿病早期肾损害诊断中的作用[J].广东医学,2008,29(7):1187-1188.
    [81]Alderman M H,Melchar L,Drayer D E,et al.Increased excretion of urinary N-acetylbeta-gluco sam inidase in essential hypertension and its deline with antihypertensive therapy[J].N Engl J Med,1983,309:12-13.
    [82]万莉莉,孙洞箫.尿蛋白及尿酶测定在高血压肾损害早期诊断的价值[J].中国保健(医学研究版),2007,15(4):76-77.
    [83]李宝亮,杨桂芬,明秀峰.尿微量蛋白联合尿酶诊断高血压病肾脏早期损伤[J].河北北方学院学报(医学版),2005,22(1):67-68.
    [84]戴永生.试析张仲景对体质的分类意义[J].辽宁中医杂志,1995,22(5):196-198.
    [85]王琦.2008中医体质学[M].人民卫生出版社,2009.
    [86]中华中医药学会.中医体质分类与判定(ZYYXH/T157-2009) [J].世界中西医结合杂志,2009,4(4):303-304.
    [87]王琦,朱燕波.中国一般人群中医体质流行病学调查[J].中华中医药杂志,2009,24(1):7.
    [88]张翠英,石鹤峰,李淑敏,等.河南省中医体质类型流行病学2133例调查分析.中医研究,2008,21(6):32-35.
    [89]姚实林,吴芳斌,许霞,等.1003例中医体质类型流行病学调查分析.安徵中医学院学报,2007,26(1);10-13.
    [90]苏俊.特禀体质流行病学初步研究.北京中医药大学,2007.
    [91]熊玲.气郁体质及其台北地区分布情况研究.北京中医药大学,2007.
    [92]莫润田,曾勇,吴定苏等.岭南地区居住人群中医体质调查[J].江西中医学院学报,2010,22(4):]8-19.
    [93]王琦,骆斌.肥胖人痰湿型体质与冠心病相关性研究(下)[J].江苏中医,1995,16(5):46-47.
    [94]王前飞,王前奔.肥胖人痰湿型体质的分布及其与冠心病的关系[J].云南中医杂志,1992,13(2):8.
    [95]袁兆荣,袁杰.老年中风疾病与体质因素关系[J].山东中医杂志,1997,16(6):16.
    [96]辛海,金玫,沈蔷等.北京市东城区社区中老年慢性病人群生存质量与中医九种体质的相关性分析[J].中医杂志,2011,52(2):127-130.
    [97]苏倩.冠心病中医证型及体质类型与客观指标相关性研究.北京中医药大学,2004.
    [98]朱燕波,王琦,邓棋卫等.中医体质类型与高血压的相关性研究[J].中西医结合学报,2010,8(1):41-44.
    [99]蔡光先,等.高血压病常见证候临床流行病学观察[J].中医杂志.1999,40(8):492-493.
    [100]柳洪胜,白允戴中,王少杰.从体质论治原发性高血压病[J].中华中医药杂志,2010,25(6):818-819.
    [101]2010年全国疾病监测地区(DSPs)慢性病及危险因素监测主要结果[R/OL].http:// www.chinacdc.cn/gwswxx/mbsqc/201109/120110906_52141.htm.
    [102]杨功焕,马杰民,刘娜,等.中国人群2002年吸烟和被动吸烟的现状调查[J].中华流行病学杂志,2005,26(2):77-83.
    [103]龚鹤琴.从美国的控烟经验看我国的控烟工作和今后控烟工作的重点[J].学术探索,2003(5)